SwePub
Sök i LIBRIS databas

  Utökad sökning

id:"swepub:oai:gup.ub.gu.se/108515"
 

Sökning: id:"swepub:oai:gup.ub.gu.se/108515" > Darbepoetin alfa ex...

Darbepoetin alfa exerts a cardioprotective effect in autoimmune cardiomyopathy via reduction of ER stress and activation of the PI3K/Akt and STAT3 pathways.

Mao, Weike (författare)
Iwai, Chikao (författare)
Liu, Jiahao (författare)
visa fler...
Sheu, Shey-Shing (författare)
Fu, Michael, 1963 (författare)
Gothenburg University,Göteborgs universitet,Institutionen för medicin, avdelningen för molekylär och klinisk medicin,Wallenberglaboratoriet,Institute of Medicine, Department of Molecular and Clinical Medicine,Wallenberg Laboratory
Liang, Chang-seng (författare)
visa färre...
 (creator_code:org_t)
Elsevier BV, 2008
2008
Engelska.
Ingår i: Journal of molecular and cellular cardiology. - : Elsevier BV. - 1095-8584 .- 0022-2828. ; 45:2, s. 250-60
  • Tidskriftsartikel (refereegranskat)
Abstract Ämnesord
Stäng  
  • Dilated human cardiomyopathy is associated with suppression of the prosurvival phosphatidylinositol-3-kinase (PI3K)/Akt and STAT3 pathways. The present study was carried out to determine if restoration of the PI3K/Akt and STAT3 activity by darbepoetin alfa improved cardiac function or reduced cardiomyocyte apoptosis in rabbit autoimmune cardiomyopathy induced by a peptide corresponding to the second extracellular loop of the ss(1)-adrenergic receptor (ss(1)-EC(II)). We found that ss(1)-EC(II) immunization produced progressive LV dilation, systolic dysfunction and myocyte apoptosis as measured by TUNEL, single-stranded DNA antibody, and active caspase-3. These changes were associated with activation of p38 mitogen-activated protein kinase (MAPK), endoplasmic reticulum stress markers (GRP78 and CHOP), and increased cleavage of procaspase-12, as well as decreased phosphorylation of Akt and STAT3, and decreased Bcl2/Bax ratio. As expected, darbepoetin alfa treatment increased phosphorylation of Akt and STAT3. It also increased the myocardial expression of erythropoietin receptor which was reduced in the failing myocardium, and improved cardiac function in the ss(1)-EC(II)-immunized animals. The latter was associated with reductions of myocyte apoptosis and cleaved caspase-3, as well as reversal of increased phosphorylation of p38-MAPK, increased ER stress, and decline in Bcl2/Bax ratio. The anti-apoptotic effects of darbepoetin alfa via Akt and STAT activation were also demonstrated in cultured cardiomyocytes treated with the anti-ss(1)-EC(II) antibody. These effects of darbepoetin alfa in vitro were prevented by LY294002 and STAT3 peptide inhibitor. Thus, we conclude that darbepoetin alfa improves cardiac function and prevents progression of dilated cardiomyopathy probably by activating the PI3K/Akt and STAT3 pathways and reducing ER stress.

Ämnesord

MEDICIN OCH HÄLSOVETENSKAP  -- Medicinska och farmaceutiska grundvetenskaper -- Fysiologi (hsv//swe)
MEDICAL AND HEALTH SCIENCES  -- Basic Medicine -- Physiology (hsv//eng)

Nyckelord

1-Phosphatidylinositol 3-Kinase
metabolism
Animals
Animals
Newborn
Autoimmune Diseases
drug therapy
immunology
pathology
Cardiomyopathy
Dilated
drug therapy
immunology
pathology
Cardiotonic Agents
therapeutic use
Cells
Cultured
Endoplasmic Reticulum
drug effects
Erythropoietin
analogs & derivatives
therapeutic use
Humans
Myocytes
Cardiac
drug effects
immunology
Oxidative Stress
drug effects
Proto-Oncogene Proteins c-akt
metabolism
Rabbits
Rats
Rats
Sprague-Dawley
STAT3 Transcription Factor
metabolism
Signal Transduction
drug effects
physiology

Publikations- och innehållstyp

ref (ämneskategori)
art (ämneskategori)

Hitta via bibliotek

Till lärosätets databas

Sök utanför SwePub

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Stäng

Kopiera och spara länken för att återkomma till aktuell vy